RAPID ADOPTION OF PNEUMOCOCCAL 20-VALENT CONJUGATE VACCINE (PCV20) VACCINATION IN ADULT PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Karime, Christian
Crosby, Sheena K.
Bhat, Shubha
Hashash, Jana G.
Farraye, Francis A.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1781
引用
收藏
页码：S678 / S679
页数：2
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF THE 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE VS 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR A./ULTS IN ARGENTINA
    Mac Mullen, M.
    Carballo, C.
    Seyahian, E.
    VALUE IN HEALTH, 2022, 25 (12) : S132 - S132
  • [22] Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States
    Senders, Shelly
    Klein, Nicola P.
    Lamberth, Erik
    Thompson, Allison
    Drozd, Jelena
    Trammel, James
    Peng, Yahong
    Giardina, Peter C.
    Jansen, Kathrin U.
    Gruber, William C.
    Scott, Daniel A.
    Watson, Wendy
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (10) : 944 - 951
  • [23] COST-EFFECTIVENESS OF 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN MEXICAN ADULTS POPULATION
    Huerta, J. L.
    Ta, A.
    Freigofaite, D.
    Torres, G., I
    Wannaadisai, W.
    Huang, L.
    VALUE IN HEALTH, 2024, 27 (06) : S68 - S68
  • [24] Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England
    Mugwagwa, Tendai
    Averin, Ahuva
    Atwood, Mark
    Sato, Reiko
    Vyse, Andrew
    Campling, James
    Weycker, Derek
    Slack, Mary
    Ellsbury, Gillian
    Mendes, Diana
    EXPERT REVIEW OF VACCINES, 2022, 21 (09) : 1331 - 1341
  • [25] COST-EFFECTIVENESS ASSESSMENT OF 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HONG KONG
    Huang, L.
    Shami, J.
    Georgiou, T.
    Wong, V
    Wong, C.
    VALUE IN HEALTH, 2023, 26 (12) : S198 - S199
  • [26] Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany
    Kuehne, Felicitas
    Achtert, Katharina
    Pueschner, Franziska
    Urbanski-Rini, Dominika
    Schiller, Juliane
    Mahar, Ernestine
    Friedrich, Josephine
    Atwood, Mark
    Sprenger, Ralf
    Vietri, Jeffrey
    von Eiff, Christof
    Theilacker, Christian
    EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 921 - 932
  • [27] Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine
    Meroc, Estelle
    Fletcher, Mark A. A.
    Hanquet, Germaine
    Slack, Mary P. E.
    Baay, Marc
    Hayford, Kyla
    Gessner, Bradford D. D.
    Grant, Lindsay R. R.
    MICROORGANISMS, 2023, 11 (07)
  • [28] Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults
    Marbaix, Sophie
    Mignon, Annick
    Taelman, Audrey
    Averin, Ahuva
    Atwood, Mark
    Vietri, Jeffrey
    EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 1008 - 1021
  • [29] A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥ 65 years of age with different prior pneumococcal vaccination
    Cannon, Kevin
    Elder, Charles
    Young, Mariano
    Scott, Daniel A.
    Scully, Ingrid L.
    Baugher, Gary
    Peng, Yahong
    Jansen, Kathrin U.
    Gruber, William C.
    Watson, Wendy
    VACCINE, 2021, 39 (51) : 7494 - 7502
  • [30] An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population
    Fridh, Ann-Charlotte
    Palmborg, Andreas
    Ta, An
    Freigofaite, Donata
    Warren, Sophie
    Perdrizet, Johnna
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
12345